schliessen

Filtern

 

Bibliotheken

MP15-13 A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2017.02.498 Byline: Guarionex DeCastro, Wilson Sui, Jamie Pak, Cory Abate-Shen, Shing Lee, Christopher Anderson, Dara Holder, James McKiernan Author Affiliation: New York, NY Article Note: (footnote) Sour... Full description

Journal Title: The Journal of Urology 2017, Vol.197(4), pp.e175-e176
Main Author: Decastro, Guarionex
Other Authors: Sui, Wilson , Pak, Jamie , Abate-Shen, Cory , Lee, Shing , Anderson, Christopher , Holder, Dara , Mckiernan, James,
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0022-5347 ; DOI: 10.1016/j.juro.2017.02.498
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: gale_ofa489014565
title: MP15-13 A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
format: Article
creator:
  • Decastro, Guarionex
  • Sui, Wilson
  • Pak, Jamie
  • Abate-Shen, Cory
  • Lee, Shing
  • Anderson, Christopher
  • Holder, Dara
  • Mckiernan, James
subjects:
  • Antineoplastic Agents – Usage
  • Antineoplastic Agents – Product Development
ispartof: The Journal of Urology, 2017, Vol.197(4), pp.e175-e176
description: To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2017.02.498 Byline: Guarionex DeCastro, Wilson Sui, Jamie Pak, Cory Abate-Shen, Shing Lee, Christopher Anderson, Dara Holder, James McKiernan Author Affiliation: New York, NY Article Note: (footnote) Source of Funding: none
language: eng
source:
identifier: ISSN: 0022-5347 ; DOI: 10.1016/j.juro.2017.02.498
fulltext: fulltext
issn:
  • 0022-5347
  • 00225347
url: Link


@attributes
ID1023384193
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid489014565
sourceidgale_ofa
recordidTN_gale_ofa489014565
sourceformatXML
sourcesystemOther
galeid489014565
display
typearticle
titleMP15-13 A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
ispartofThe Journal of Urology, 2017, Vol.197(4), pp.e175-e176
identifierISSN: 0022-5347 ; DOI: 10.1016/j.juro.2017.02.498
subjectAntineoplastic Agents – Usage ; Antineoplastic Agents – Product Development
descriptionTo link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2017.02.498 Byline: Guarionex DeCastro, Wilson Sui, Jamie Pak, Cory Abate-Shen, Shing Lee, Christopher Anderson, Dara Holder, James McKiernan Author Affiliation: New York, NY Article Note: (footnote) Source of Funding: none
languageeng
source
creatorDecastro, Guarionex ; Sui, Wilson ; Pak, Jamie ; Abate-Shen, Cory ; Lee, Shing ; Anderson, Christopher ; Holder, Dara ; Mckiernan, James;
version3
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
search
scope
0gale_onefilea
1OneFile
titleMP15-13 A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER.
descriptionTo link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2017.02.498 Byline: Guarionex DeCastro, Wilson Sui, Jamie Pak, Cory Abate-Shen, Shing Lee, Christopher Anderson, Dara Holder, James McKiernan Author Affiliation: New York, NY Article Note: (footnote) Source of Funding: none
subject
0Antineoplastic agents–Usage
1Antineoplastic agents–Product development
22834
3Pharmaceutical preparations
4Pharmaceutical Preparation Manufacturing
5325412
general
010.1016/j.juro.2017.02.498
1English
2Elsevier B.V.
3Cengage Learning, Inc.
sourceidgale_ofa
recordidgale_ofa489014565
issn
00022-5347
100225347
rsrctypearticle
creationdate2017
startdate20170401
enddate20170401
recordtypearticle
addtitleThe Journal of Urology
searchscopeOneFile
citationpf e175 pt e176 vol 197 issue 4
lsr30VSR-Enriched:[pages, eissn, creator, date, galeid]
sort
titleMP15-13 A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER.
creationdate20170401
lso0120170401
facets
frbrgroupid6064949471657045125
frbrtype5
newrecords20170510
languageeng
creationdate2017
topic
0Antineoplastic Agents–Usage
1Antineoplastic Agents–Product Development
collectionOneFile (GALE)
prefilterarticles
rsrctypearticles
jtitleJournal of Urology
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
atitleMP15-13 A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
jtitleThe Journal of Urology
risdate20170401
volume197
issue4
spagee175
epagee176
issn0022-5347
formatjournal
genrearticle
ristypeJOUR
abstractTo link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2017.02.498 Byline: Guarionex DeCastro, Wilson Sui, Jamie Pak, Cory Abate-Shen, Shing Lee, Christopher Anderson, Dara Holder, James McKiernan Author Affiliation: New York, NY Article Note: (footnote) Source of Funding: none
pubElsevier B.V.
doi10.1016/j.juro.2017.02.498
lad01gale_ofa
pagese175-e176
eissn15273792
date2017-04